Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two estrogen doses after hysteroscopic treatment of Asherman syndrome
IRCT20141230020486N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of conjugated estrogens and medroxyprogesterone acetate in Intrauterine Adhesions (IUA) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Frequency of synechia, Intensity of synechia and 5 more. Started Jun 2017; status: completed.
02
Drugs
conjugated estrogensmedroxyprogesterone acetate
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on IRCT20141230020486N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141230020486N3.